Mutagenesis, Vol. 16, No. 2, 155-161,
March 2001
© 2001 UK Environmental Mutagen Society/Oxford University Press
Genotoxins and the initiation of sporadic breast cancer
Institute of Cancer Research, Haddow Laboratories, Cotswold Road, Sutton, Surrey SM2 5NG, UK
Breast cancer is the most frequently diagnosed female malignancy world-wide. The aetiology of the majority of cases remains obscure and the only genotoxin as yet known to initiate breast cancer is ionizing radiation. High penetrance susceptibility genes probably account for no more than 5–10% of cases. The breast, which consists of 70–90% adipose tissue, has a unique morphological structure. Dispersed within it are the functional elements that are lined with cancer-susceptible epithelial cells. Numerous dietary and/or environmental fat-soluble compounds are known to be rodent mammary carcinogens. Extracts of lipid obtained following collagenase digestion of elective reduction mammoplasty tissues from UK resident women showed activity in short-term genotoxicity assays in 40% of cases. More active lipid extracts tended to come from donors whose human mammary epithelial cells (HMECs) exhibited pre-existing DNA single-strand breaks (SSBs). Lipid extracts also induced morphological transformation of mammalian cells in vitro. To increase cohort size, extracts of UK breast milk were examined for genotoxicity and similar activity profiles were observed. Viable cells, a large percentage of which were HMECs, were recovered from breast milk and examined for pre-existing SSBs and for the ability of the donor's own milk extract to induce SSBs. Again, donors whose untreated cells contained the most SSBs tended to yield genotoxic breast milk extracts. Breast milk cells were also able to activate rodent mammary carcinogens to DNA-damaging species. These studies provide good evidence for in vivo exposure of HMECs to genotoxic agents years before the peak in occurrence of sporadic breast cancer. Work is in progress to characterize these agents and to determine their possible role in breast cancer aetiology.
Tel: +44 20 8643 8901; Fax: +44 20 8770 7290; Email:flmartin{at}icr.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Ninomiya, H. Kawaguchi, M. Souda, S. Taguchi, M. Funato, Y. Umekita, and H. Yoshida Effects of Neonatally Administered Diethylstilbestrol on Induction of Mammary Carcinomas Induced by 7, 12-Dimethylbenz[A]Anthracene in Female Rats Toxicol Pathol, October 1, 2007; 35(6): 811 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Davis, S. Bhana, A. J. Shorrocks, and F. L. Martin Oestrogens induce G1 arrest in benzo[a]pyrene-treated MCF-7 breast cells whilst enhancing genotoxicity and clonogenic survival Mutagenesis, September 1, 2002; 17(5): 431 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Yared, T. J. McMillan, and F. L. Martin Genotoxic effects of oestrogens in breast cells detected by the micronucleus assay and the Comet assay Mutagenesis, July 1, 2002; 17(4): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Grover and F. L. Martin The initiation of breast and prostate cancer Carcinogenesis, July 1, 2002; 23(7): 1095 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L. Martin, K. J. Cole, G. Weaver, G. S. Hong, B. C. Lam, P. Balaram, P. L. Grover, and D. H. Phillips Genotoxicity of human breast milk from different countries Mutagenesis, September 1, 2001; 16(5): 401 - 406. [Abstract] [Full Text] [PDF]
|
|